2020 Germany Hospital Clinical Chemistry and Immunodiagnostics Market for 100 Tests: Supplier Shares, Volume and and Sales Forecasts, Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

This new report contains 523 pages, 64 tables, and presents a comprehensive analysis of the German hospital clinical chemistry and immunodiagnostics market, including: 

  • Major issues pertaining to the German clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in German hospitals, including controls, calibrators and consumables. 
  • Five-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.
  • Five-year reagent and instrument sales forecasts. 
  • Review of current instrumentation technologies, and a feature comparison
    of high-, medium-, and low-volume/POC analyzers. 
  • Sales and market shares of leading reagent and instrument suppliers. 
  • Review of current and emerging technologies and their potential market applications. 
  • Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. 
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • /ul>
    • Market penetration strategies, entry barriers and risks.


      Introduction
      Market and Technology Overview
      A. Major Routine Chemistry Tests
      1. Albumin
      2. Alkaline Phosphatase
      3. ALT/SGPT
      4. Ammonia
      5. Amylase
      6. AST/SGOT
      7. Bilirubin, Total
      8. Blood Gases
      9. Blood Urea Nitrogen (BUN)
      10. Calcium
      11. Cardio CRP
      12. Cholesterol
      13. Cholinesterase
      14. CRP
      15. Creatinine
      16. Electrolytes
      a. Carbon Dioxide/Bicarbonate
      b. Chloride
      c. Potassium
      d. Sodium
      17. Ferritin
      18. Fructosamine
      19. Gamma-Glutamyl Transpeptidase (GGT)
      20. Glucose
      21. High Density Lipoprotein (HDL)
      22. Homocysteine
      23. Iron
      24. Lactate Dehydrogenase (LDH)
      25. Magnesium
      26. Phosphorus
      27. Protein
      28. Triglycerides
      29. Uric Acid
      30. Troponin

      B. Therapeutic Drug Monitoring (TDM)
      1. Overview
      2. Carbamazepine
      3. Cyclosporin
      4. Digoxin
      5. Everolimus
      6. Gentamicin
      7. Lamotrigine/Lamictal
      8. Levetiracetam
      9. Lidocaine
      10. Lithium
      11. NAPA/Procainamide
      12. Phenytoin
      13. Quinidine
      14. Sirolimus
      15. Tacrolimus
      16. Theophylline
      17. Topirimate
      18. Valproic Acid
      C. Endocrine Function Tests
      1. Cortisol
      2. Estradiol
      3. Follicle-Stimulating Hormone (FSH)
      4. Gastrin
      5. Growth Hormone/IGF-1
      6. Human Chorionic Gonadotropin (HCG)
      7. LH
      8. Progesterone
      9. PTH/IO PTH
      10. Prolactin
      11. T3
      12. T3 Free
      13. T3 Uptake
      14. T4 (Thyroxine)
      15. T4 Free
      16. TBG
      17. Testosterone
      18. Thyroglobulin Ab
      19. TPO Ab
      20. TSH

      D. Tumor Markers And Special Chemistry Tests
      1. AFP
      2. CA 15-3
      3. CA 19-9
      4. CA 27-29
      5. Carcinoembrionic Antigen (CEA)
      6. Folate/Folic Acid
      7. HCG
      8. 25-Hydroxy Vitamin D2 and D3
      9. Occult Blood
      10. Prostate-Specific Antigen (PSA)
      11. Thyroglobulin
      12. Vitamin B-12
      E. Immunoprotein Tests
      1. Complement
      a. C3
      b. C4
      2. Free Light Chains
      3. Immunofixation
      4. Immunoglobulins (IgA, IgE, IgG, IgM)
      5. Haptoglobin
      6. Prealbumin
      7. Protein Electrophoresis
      F. Drugs of Abuse
      1. Overview
      2. Test Methodologies
      3. Amphetamines
      4. Barbiturates
      5. Benzodiazepines
      6. Cannabinoids/Marijuana
      7. Cocaine
      8. Lysergic Acid Diethylamide (LSD)
      9. Methadone
      10. Methaqualone
      11. Opiates
      12. Phencyclidine
      13. Tricyclic Antidepressants

      G. Instrumentation Review: Operating Characteristics
      and Features of High-, Medium-, and Low- Volume/POC
      Analyzers Manufactured By:
      Abaxis
      Abbott
      Alere/Inverness
      Alfa Wassermann
      AMS
      Awareness Technologies
      Beckman Coulter/Olympus
      Binding Site
      bioMerieux
      Carolina Chemistries
      DiaSorin
      Grifols
      Horiba
      Medica
      Nova Biomedical
      Ortho-Clinical Diagnostics
      Polymedco
      Randox
      Roche
      Siemens
      Tosoh
      Vital Diagnostics
      H. Major In Vitro Diagnostic Technologies
      And Their Potential Applications
      1. Monoclonal and Polyclonal Antibodies
      2. Immunoassays
      a. Technological Principle
      d. Chemiluminescence
      c. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      EMIT
      Electrochemical

      d. Radioimmunoassays (RIA)
      e. Immunoprecipitation
      f. Affinity Chromatography
      3. Tandem Mass Spec
      4. IT and Automation
      5. Dry Chemistry
      6. Biosensors
      Country Analysis
      A. Executive Summary
      B. Business Environment
      C. Market Structure
      D. Market Size, Growth and Major Suppliers
      Instrument and Reagent Sales and Market Shares
      Major Product Development Opportunities
      Design Criteria for Decentralized Testing Products
      Alternative Market Penetration Strategies
      A. Internal Development
      B. Collaborative Arrangements
      C. University Contracts
      D. Distribution Strategies for Decentralized Testing Markets
      1. Marketing Approaches
      2. Product Complexity
      3. Customer Preference
      4. Established Suppliers
      5. Emerging Suppliers
      6. Major Types of Distributors
      7. Market Segmentation

      Potential Market Entry Barriers and Risks
      A. Market Maturity
      B. Cost Containment
      C. Competition
      D. Technological Edge and Limitations
      E. Patent Protection
      F. Regulatory Constraints
      G. Decentralized Testing Market Challenges
      Competitive Assessments
      Abbott
      Agilent Technologies
      Beckman Coulter/Danaher
      bioMerieux
      Bio-Rad
      DiaSorin
      Eiken Chemical
      Fujirebio
      Grifols
      IL/Werfen
      Kyowa Medex
      Ortho-Clinical Diagnostics
      PerkinElmer
      Quest Diagnostics
      Roche
      Siemens Healthineers
      Sysmex
      Thermo Fisher
      Tosoh
      Wako

      List Of Tables


      Major Companies Developing or Marketing
      Albumin Tests
      Major Companies Developing or Marketing
      Alkaline Phosphatase Tests
      Major Companies Developing or Marketing
      ALT/SGPT Tests
      Major Companies Developing or Marketing
      Amylase Tests
      Major Companies Developing or Marketing
      AST/SGOT Tests
      Major Companies Developing or Marketing
      Bilirubin Tests
      Major Companies Developing or Marketing
      Blood Gas Analyzers
      Major Companies Developing or Marketing
      BUN Tests
      Major Companies Developing or Marketing
      Calcium Tests
      Major Companies Developing or Marketing
      Cholesterol Tests
      Major Companies Developing or Marketing
      Creatinine Tests
      Major Companies Developing or Marketing
      Electrolyte Tests

      Major Companies Developing or Marketing
      GGT Tests
      Major Companies Developing or Marketing
      Glucose Tests
      Major Companies Developing or Marketing
      HDL Tests
      Major Companies Developing or Marketing
      Iron Tests
      Major Companies Developing or Marketing
      LDH Tests
      Major Companies Developing or Marketing
      Magnesium Tests
      Major Companies Developing or Marketing
      Phosphorus Tests
      Major Companies Developing or Marketing
      Protein Tests
      Major Companies Developing or Marketing
      Triglycerides Tests
      Major Companies Developing or Marketing
      Uric Acid Tests
      Major Companies Developing or Marketing
      TDM Tests
      Major Companies Developing or Marketing
      Digoxin Tests
      Major Companies Developing or Marketing
      Lithium Tests
      Major Companies Developing or Marketing
      Phenytoin Tests

      Major Companies Developing or Marketing
      Theophylline Tests
      Major Companies Developing or Marketing
      Valproic Acid Tests
      Major Companies Developing or Marketing
      FSH Tests
      Major Companies Developing or Marketing
      HCG Tests
      Major Companies Developing or Marketing
      LH Tests
      Major Companies Developing or Marketing
      Prolactin Tests
      Major Companies Developing or Marketing
      T3 Tests
      Major Companies Developing or Marketing
      T4 Tests
      Major Companies Developing or Marketing
      TSH Tests
      Major Companies Developing or Marketing
      AFP Tests
      Major Companies Developing or Marketing
      CEA Tests
      Major Companies Developing or Marketing
      Ferritin Tests
      Major Companies Developing or Marketing
      Occult Blood Tests
      Major Companies Developing or Marketing
      Prostatic Acid Phosphatase Tests

      Major Companies Developing or Marketing
      PSA Tests
      Major Companies Developing or Marketing
      Vitamin B-12/Folate Tests
      Major Companies Developing or Marketing
      CRP Tests
      Major Companies Developing or Marketing
      Drugs of Abuse Tests
      Major Companies Developing or Marketing
      Biosensors for Clinical Chemistry Testing
      Executive Summary Table: France, Clinical
      Chemistry and Immunoassay Test Volume and
      Diagnostics Sales Forecast By Test Category
      France, Hospital Laboratories Performing
      Chemistry and Immunoassay Tests
      By Bed Size
      France, Hospital Laboratories, Profiles,
      Panels and Individual Tests Forecast
      France, Hospital Laboratories, Routine
      Chemistry Test Volume Forecast by Assay
      France, Hospital Laboratories, Endocrine
      Function Test Volume Forecast by Assay
      France, Hospital Laboratories, Tumor Markers
      and Special Chemistry Test Volume Forecast
      by Assay
      France, Hospital Laboratories,
      Immunoprotein Test Volume Forecast
      by Assay

      France, Hospital Laboratories, TDM
      Test Volume Forecast by Assay
      France, Hospital Laboratories, Drugs
      of Abuse Test Volume Forecast
      by Assay
      France, Clinical Chemistry and
      Immunoassay Calibrator and Control Market
      Forecast By Test Category
      France, Hospital Laboratories, Routine
      Chemistry Reagent Market Forecast
      by Assay
      France, Hospital Laboratories, Endocrine
      Function Reagent Market Forecast
      by Assay
      France, Hospital Laboratories, Tumor Markers
      and Special Chemistry Reagent Market Forecast
      by Assay
      France, Hospital Laboratories,
      Immunoprotein Reagent Market Forecast
      by Assay
      France, Hospital Laboratories, TDM
      Reagent Market Forecast by Assay
      France, Hospital Laboratories, Drugs of
      Abuse Reagent Market Forecast by Assay
      France, Clinical Chemistry and Immunoassay
      Instrument Market Forecast By Analyzer Type
      France, Major Suppliers of Clinical
      Chemistry Diagnostic Products, Estimated Sales
      and Market Shares
      France, Major Suppliers of Immunoassay
      Diagnostic Products, Estimated Sales
      and Market Shares

      2020 Denmark Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

      This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective

      USD 2450 View Report

      2020 Czech Republic Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

      This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective

      USD 2450 View Report

      2020 Germany Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities

      This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the German molecular blood banking market during the next five years,

      USD 4500 View Report

      2020 Germany Respiratory Disease Testing Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

      About This ReportThis new 283-page report presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV

      USD 2450 View Report

      Fill The Form For Sample Request

      Note : * Kindly provide us with your company id and get the sample reports at the earliest.

      There is no Reviews available